argenx SE (ARGNF)
OTCMKTS
· Delayed Price · Currency is USD
562.00
+11.04 (2.00%)
At close: May 12, 2025
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$1,652,947
Profits / Employee
$665,482
Market Cap
36.13B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
American Oncology Network | 1,914 |
argenx SE News
- 1 day ago - Hot Picks in biotech: argenx, Scholar Rock & Kiniksa - BNN Bloomberg
- 10 days ago - Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? - Benzinga
- 12 days ago - Argenx Q1 Earnings: Less Than Perfect Report Gets Punished - Seeking Alpha
- 13 days ago - Argenx targets Vision 2030 with 50,000 patients and 10 labeled indications by 2025 - Seeking Alpha
- 13 days ago - argenx SE (ARGX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Argenx plunges after Q1 revenue miss - Seeking Alpha
- 13 days ago - Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble - Investor's Business Daily
- 14 days ago - Earnings Scheduled For May 8, 2025 - Benzinga